Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Spence

Showing results (391-400 of 406) with videos related to

Pageof 41
Sort By:
International Journal of Clinical Oncology|November 20, 2014
A Phase III study of radiation therapy (RT) and O⁶-benzylguanine + BCNU versus RT and BCNU alone and methylation status in newly diagnosed glioblastoma and gliosarcoma: Southwest Oncology Group (SWOG) study S0001Deborah T Blumenthal, Cathryn Rankin, Keith J Stelzer, et al.
Biochemical Society Symposium|March 27, 2003
Functional post-translational proteomics approach to study the role of N-glycans in the development of Caenorhabditis elegansHarry Schachter, Shihao Chen, Wenli Zhang, et al.
Cancer Research|November 26, 2009
Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical modelChristina H Wang, Jason K Rockhill, Maciej Mrugala, et al.
Cancer|June 4, 2008
External beam irradiation and the combination of cisplatin and carmustine followed by carmustine alone for the treatment of high-grade glioma: a phase 2 Southwest Oncology Group trialDeborah T Blumenthal, Cathryn Rankin, Harmon J Eyre, et al.
Blood Advances|June 28, 2023
Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphomaW Richard Burack, Hongli Li, Diana Adlowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Phase II study of paclitaxel in patients with recurrent malignant gliomaM D Prados, S C Schold, A M Spence, et al.
Mathematical Medicine and Biology : a Journal of the IMA|May 13, 2011
Applying a patient-specific bio-mathematical model of glioma growth to develop virtual [18F]-FMISO-PET imagesStanley Gu, Gargi Chakraborty, Kyle Champley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase II study of phenylacetate in patients with recurrent malignant glioma: a North American Brain Tumor Consortium reportS M Chang, J G Kuhn, H I Robins, et al.
Behavioral Sciences (Basel, Switzerland)|June 27, 2023
Factors Influencing Receipt and Type of Therapy Services in the NICUChristiana D Butera, Shaaron E Brown, Jennifer Burnsed, et al.
International Journal of Circumpolar Health|September 23, 2022
Implementation and evaluation of a two-eyed seeing approach using traditional healing and seeking safety in an indigenous residential treatment program in Northern OntarioT N Marsh, C Eshakakogan, J K Eibl, et al.
Pageof 41

Showing results (391-400 of 406) with videos related to

Sort By:
Pageof 41
International Journal of Clinical Oncology|November 20, 2014
A Phase III study of radiation therapy (RT) and O⁶-benzylguanine + BCNU versus RT and BCNU alone and methylation status in newly diagnosed glioblastoma and gliosarcoma: Southwest Oncology Group (SWOG) study S0001Deborah T Blumenthal, Cathryn Rankin, Keith J Stelzer, et al.
Biochemical Society Symposium|March 27, 2003
Functional post-translational proteomics approach to study the role of N-glycans in the development of Caenorhabditis elegansHarry Schachter, Shihao Chen, Wenli Zhang, et al.
Cancer Research|November 26, 2009
Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical modelChristina H Wang, Jason K Rockhill, Maciej Mrugala, et al.
Cancer|June 4, 2008
External beam irradiation and the combination of cisplatin and carmustine followed by carmustine alone for the treatment of high-grade glioma: a phase 2 Southwest Oncology Group trialDeborah T Blumenthal, Cathryn Rankin, Harmon J Eyre, et al.
Blood Advances|June 28, 2023
Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphomaW Richard Burack, Hongli Li, Diana Adlowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Phase II study of paclitaxel in patients with recurrent malignant gliomaM D Prados, S C Schold, A M Spence, et al.
Mathematical Medicine and Biology : a Journal of the IMA|May 13, 2011
Applying a patient-specific bio-mathematical model of glioma growth to develop virtual [18F]-FMISO-PET imagesStanley Gu, Gargi Chakraborty, Kyle Champley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase II study of phenylacetate in patients with recurrent malignant glioma: a North American Brain Tumor Consortium reportS M Chang, J G Kuhn, H I Robins, et al.
Behavioral Sciences (Basel, Switzerland)|June 27, 2023
Factors Influencing Receipt and Type of Therapy Services in the NICUChristiana D Butera, Shaaron E Brown, Jennifer Burnsed, et al.
International Journal of Circumpolar Health|September 23, 2022
Implementation and evaluation of a two-eyed seeing approach using traditional healing and seeking safety in an indigenous residential treatment program in Northern OntarioT N Marsh, C Eshakakogan, J K Eibl, et al.
Pageof 41